Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. EVANS SM, Ivanova K, Cossio D, Pilgrim CHC, et al
    Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia.
    PLoS One. 2024;19:e0294443.
    >> Share

  2. SECHRIST ZR, Lee G, Schwarz EM, Cole CL, et al
    Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0292196.
    >> Share

  3. HUANG H, Huang Z, Chen M, Okamoto K, et al
    Evaluation of the therapeutic efficiency and efficacy of blood purification in the treatment of severe acute pancreatitis.
    PLoS One. 2024;19:e0296641.
    >> Share

  4. KHRISTENKO E, Sinitsyn V, Rieden T, Girod P, et al
    CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    PLoS One. 2024;19:e0291185.
    >> Share


  5. Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer.
    PLoS One. 2024;19:e0298197.
    >> Share

  6. KORDSHOULI SO, Tahmasebi A, Moghadam A, Ramezani A, et al
    A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0289561.
    >> Share


  7. Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.
    PLoS One. 2024;19:e0298557.
    >> Share

  8. TUSHOSKI-ALEMAN GW, Herremans KM, Underwood PW, Akki A, et al
    Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
    PLoS One. 2024;19:e0297325.
    >> Share

  9. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    >> Share

  10. HUAN L, Yu F, Cao D, Zhou H, et al
    Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0295983.
    >> Share

  11. GRIFFIN JI, Chen X, Duan L, Mu Q, et al
    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
    PLoS One. 2024;19:e0300723.
    >> Share

  12. LANG H, Lin N, Chen X, Xiang J, et al
    Repressing miR-23a promotes the transdifferentiation of pancreatic alpha cells to beta cells via negatively regulating the expression of SDF-1alpha.
    PLoS One. 2024;19:e0299821.
    >> Share

  13. ZHANG C, Lin F, Guo DF, Wang QL, et al
    Assessing the causal link between liver function and acute pancreatitis: A Mendelian randomisation study.
    PLoS One. 2024;19:e0300890.
    >> Share

  14. MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
    Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0301271.
    >> Share

  15. HAWKINS HJ, Yacob BW, Brown ME, Goldstein BR, et al
    Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
    PLoS One. 2024;19:e0298808.
    >> Share

  16. SASAKI Y, Inouchi T, Nakatsuka R, Inoue A, et al
    Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells.
    PLoS One. 2024;19:e0302130.
    >> Share

    January 2023
  17. IKEZAWA K, Tanaka S, Fukuda J, Nakao M, et al
    Main pancreatic duct dilatation and pancreatic cysts in relatives and spouses of patients with pancreatic cancer.
    PLoS One. 2023;18:e0280403.
    >> Share

  18. HA CSR, Muller-Nurasyid M, Petrera A, Hauck SM, et al
    Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning.
    PLoS One. 2023;18:e0280399.
    >> Share

  19. ACHTERBERG FB, Mulder BGS, Janssen QP, Koerkamp BG, et al
    Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study.
    PLoS One. 2023;18:e0280939.
    >> Share

  20. SHAREF AY, Hamdi BA, Alrawi RA, Ahmad HO, et al
    Onopordum acanthium L. extract attenuates pancreatic beta-Cells and cardiac inflammation in streptozocin-induced diabetic rats.
    PLoS One. 2023;18:e0280464.
    >> Share

  21. OBONYO D, Uslar VN, Munding J, Weyhe D, et al
    The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis.
    PLoS One. 2023;18:e0281921.
    >> Share

  22. BIEL TG, Petrovskaya S, Mascia F, Ju T, et al
    Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.
    PLoS One. 2023;18:e0281182.
    >> Share

  23. TIAN W, Zhang L, Liu X, Ma X, et al
    Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0282360.
    >> Share

  24. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    >> Share

  25. BASNET S, Ghimire MP, Lamichhane TR, Adhikari R, et al
    Identification of potential human pancreatic alpha-amylase inhibitors from natural products by molecular docking, MM/GBSA calculations, MD simulations, and ADMET analysis.
    PLoS One. 2023;18:e0275765.
    >> Share

  26. WANG L, Luo P, Yang Z, Zhong X, et al
    FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
    PLoS One. 2023;18:e0280794.
    >> Share

  27. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    >> Share

  28. CHEN Q, Lin J, Chen Z, Che L, et al
    Circular RNA expression alterations and function prediction in OSA-induced pancreatic injury in mice: New insights into pathogenesis.
    PLoS One. 2023;18:e0284459.
    >> Share

  29. HENG X, Chen B, Zhao K, Li J, et al
    Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    PLoS One. 2023;18:e0284930.
    >> Share

  30. SHIM JY, Chung JO, Jung D, Kang PS, et al
    Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells.
    PLoS One. 2023;18:e0281496.
    >> Share

  31. XIAO X, Wu X, Fu Q, Ren X, et al
    Efficacy and safety of Dachaihu Decoction for acute pancreatitis: Protocol for a systematic review and meta-analysis.
    PLoS One. 2023;18:e0285661.
    >> Share

  32. DIKE CR, Sun QK, Rahib L, Golden M, et al
    Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report.
    PLoS One. 2023;18:e0288337.
    >> Share

  33. AMINI M, Azizmohammad Looha M, Rahimi Pordanjani S, Asadzadeh Aghdaei H, et al
    Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data.
    PLoS One. 2023;18:e0288755.
    >> Share

  34. LING R, Liang J, Mo S, Qi J, et al
    Physical activity, sedentary behavior and pancreatitis risk: Mendelian randomization study.
    PLoS One. 2023;18:e0287810.
    >> Share

  35. SHIMAGAKI T, Sugimachi K, Mano Y, Tomino T, et al
    A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    PLoS One. 2023;18:e0288033.
    >> Share

  36. HEINZMAN C, Hornung L, Lin TK, Lowe CMO, et al
    Total pancreatectomy with islet autotransplantation reduces opioid use and improves nutritional support in children with debilitating pancreatitis.
    PLoS One. 2023;18:e0289620.
    >> Share

  37. KAUR G, Helmer RA, Martinez-Marin D, Sennoune SR, et al
    Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic beta cells resulting in neonatal lethality.
    PLoS One. 2023;18:e0286109.
    >> Share

  38. ZHANG Y, Kirk CA, Tolbert MK, Steiner JM, et al
    Impact of fatty acid composition on markers of exocrine pancreatic stimulation in dogs.
    PLoS One. 2023;18:e0290555.
    >> Share

  39. LIU S, Li H, Xue Y, Yang L, et al
    Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0290888.
    >> Share

  40. LAPIN M, Tjensvoll K, Nedrebo K, Taksdal E, et al
    Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
    PLoS One. 2023;18:e0291623.
    >> Share

  41. JANTHONGKAW A, Klaophimai S, Khampaya T, Yimthiang S, et al
    Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2023;18:e0291738.
    >> Share


  42. Ex pression of Concern: Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0292422.
    >> Share

  43. AZEVEDO-POULY A, Hale MA, Swift GH, Hoang CQ, et al
    Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation.
    PLoS One. 2023;18:e0291512.
    >> Share

  44. BRAYER KJ, Hanson JA, Cingam S, Martinez C, et al
    The inflammatory response of human pancreatic cancer samples compared to normal controls.
    PLoS One. 2023;18:e0284232.
    >> Share

  45. INGLE K, LaComb JF, Graves LM, Baines AT, et al
    AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
    PLoS One. 2023;18:e0294065.
    >> Share


  46. Retraction: Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer.
    PLoS One. 2023;18:e0294385.
    >> Share

  47. GANDIKOTA HP, S A, M SK
    CT scan pancreatic cancer segmentation and classification using deep learning and the tunicate swarm algorithm.
    PLoS One. 2023;18:e0292785.
    >> Share


  48. Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0294622.
    >> Share

  49. DAILEY KM, Small JM, Pullan JE, Winfree S, et al
    An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
    PLoS One. 2023;18:e0289183.
    >> Share

  50. KARBHARI A, Mosessian S, Trivedi KH, Valla F Jr, et al
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
    PLoS One. 2023;18:e0294564.
    >> Share

  51. KANAPARTHY NS, Loza AJ, Hauser RG
    Crawling toward obsolescence: The extended lifespan of amylase for pancreatitis.
    PLoS One. 2023;18:e0296180.
    >> Share

    January 2022
  52. KRUGER D, Lahoud N, Yako YY, Devar J, et al
    Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.
    PLoS One. 2022;17:e0262439.
    >> Share

  53. ALVES FAV, Oliveira LLS, Salomao NG, Provance DW Jr, et al
    Cytokines and inflammatory mediators: Markers involved in interstitial damage to the pancreas in two dengue fever cases associated with acute pancreatitis.
    PLoS One. 2022;17:e0262785.
    >> Share

  54. KARKI B, Thapa S, Khadka D, Karki S, et al
    Intravenous Ringers lactate versus normal saline for predominantly mild acute pancreatitis in a Nepalese Tertiary Hospital.
    PLoS One. 2022;17:e0263221.
    >> Share


  55. Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2022;17:e0263037.
    >> Share

  56. MUHAMMADZAI J, Haider K, Moser M, Chalchal H, et al
    Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.
    PLoS One. 2022;17:e0263250.
    >> Share

  57. RYDENFELT K, Strand-Amundsen R, Horneland R, Hodnebo S, et al
    Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model.
    PLoS One. 2022;17:e0262848.
    >> Share

  58. LUIKEN I, Eisenmann S, Garbe J, Sternby H, et al
    Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severity.
    PLoS One. 2022;17:e0263739.
    >> Share

  59. VITALE DS, Lahni P, Hornung L, Thompson T, et al
    Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis.
    PLoS One. 2022;17:e0261708.
    >> Share

  60. YAMAI T, Ikezawa K, Hiraga E, Kawamoto Y, et al
    Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
    PLoS One. 2022;17:e0264653.
    >> Share

  61. TANIUCHI K, Ueno M, Yokose T, Sakaguchi M, et al
    Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.
    PLoS One. 2022;17:e0265172.
    >> Share

  62. GARDNER KP, Tsai S, Aldakkak M, Gironda S, et al
    CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
    PLoS One. 2022;17:e0264763.
    >> Share

  63. STHIJNS MMJPE, Rademakers T, Oosterveer J, Geuens T, et al
    The response of three-dimensional pancreatic alpha and beta cell co-cultures to oxidative stress.
    PLoS One. 2022;17:e0257578.
    >> Share

  64. DONG Y, Ruano SH, Mishra A, Pennington KA, et al
    Adrenomedullin and its receptors are expressed in mouse pancreatic beta-cells and suppresses insulin synthesis and secretion.
    PLoS One. 2022;17:e0265890.
    >> Share

  65. ARNOLETTI JP, Reza J, Rosales A, Monreal A, et al
    Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    PLoS One. 2022;17:e0265725.
    >> Share

  66. MURATA Y, Ogura T, Hayasaki A, Gyoten K, et al
    Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
    PLoS One. 2022;17:e0264573.
    >> Share

  67. KUMSTEL S, Schreiber T, Goldstein L, Stenzel J, et al
    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
    PLoS One. 2022;17:e0266601.
    >> Share

  68. UWAGAWA T, Sakamoto T, Gocho T, Shiba H, et al
    Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
    PLoS One. 2022;17:e0267623.
    >> Share

  69. NURMI AM, Hagstrom J, Mustonen H, Seppanen H, et al
    The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
    PLoS One. 2022;17:e0267792.
    >> Share

  70. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    >> Share

  71. YAMAKAWA K, Koyanagi-Aoi M, Uehara K, Masuda A, et al
    Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0266620.
    >> Share

  72. THEGE FI, Cardle II, Gruber CN, Siemann MJ, et al
    Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids.
    PLoS One. 2022;17:e0267882.
    >> Share

  73. IWATATE Y, Yokota H, Hoshino I, Ishige F, et al
    Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer.
    PLoS One. 2022;17:e0268630.
    >> Share

  74. KASSAY N, Toldi V, Tozser J, Szabo A, et al
    Cigarette smoke toxin hydroquinone and misfolding pancreatic lipase variant cooperatively promote endoplasmic reticulum stress and cell death.
    PLoS One. 2022;17:e0269936.
    >> Share

  75. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    >> Share

  76. SAKAMOTO T, Makinoya M, Sunaguchi T, Goto K, et al
    Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
    PLoS One. 2022;17:e0271073.
    >> Share

  77. HARPER MM, Lin M, Cavnar MJ, Pandalai PK, et al
    Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.
    PLoS One. 2022;17:e0270832.
    >> Share

  78. DASGUPTA R, Jebasingh FK, Anoop S, Seenivasan S, et al
    Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India.
    PLoS One. 2022;17:e0270788.
    >> Share

  79. LI Y, Maedler K, Shu L, Haataja L, et al
    Correction: UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells.
    PLoS One. 2022;17:e0271783.
    >> Share

  80. SAITO D, Nakagawa Y, Sato T, Fukunaka A, et al
    Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic gamma cells.
    PLoS One. 2022;17:e0269958.
    >> Share

  81. KNOCHE SM, Brumfield GL, Goetz BT, Sliker BH, et al
    The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
    PLoS One. 2022;17:e0273518.
    >> Share


  82. Retraction: Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets.
    PLoS One. 2022;17:e0275582.
    >> Share

  83. LEMANSKA A, Price CA, Jeffreys N, Byford R, et al
    BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
    PLoS One. 2022;17:e0275369.
    >> Share

  84. SHEBANITS K, Andersson-Assarsson JC, Larsson I, Carlsson LMS, et al
    Correction: Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference.
    PLoS One. 2022;17:e0276288.
    >> Share

  85. AGAWA S, Futagami S, Yamawaki H, Tsushima R, et al
    Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
    PLoS One. 2022;17:e0275341.
    >> Share

  86. BERKE G, Gede N, Szadai L, Ocskay K, et al
    Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: A meta-analysis.
    PLoS One. 2022;17:e0276397.
    >> Share

  87. MIYAMOTO R, Takahashi A, Ogasawara A, Ogura T, et al
    Three-dimensional simulation of the pancreatic parenchyma, pancreatic duct and vascular arrangement in pancreatic surgery using a deep learning algorithm.
    PLoS One. 2022;17:e0276600.
    >> Share

  88. OJO OA, Grant S, Amanze JC, Oni AI, et al
    Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic beta-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes.
    PLoS One. 2022;17:e0276984.
    >> Share

  89. KIM YJ, Oh CM, Park SK, Jung JY, et al
    Fasting blood glucose and risk of incident pancreatic cancer.
    PLoS One. 2022;17:e0274195.
    >> Share

  90. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    >> Share

  91. ZWART ES, Jeleniewski S, Boyd LNC, Meijer LL, et al
    Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.
    PLoS One. 2022;17:e0278377.
    >> Share

  92. BENJAKUL N, Prakobphol N, Tangshewinsirikul C, Dulyaphat W, et al
    Notch signaling regulates vasculogenic mimicry and promotes cell morphogenesis and the epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0279001.
    >> Share

  93. ABDELGAWAD R, Rathod YD, Alshammari M, Kelly L, et al
    Loss of Slc12a2 specifically in pancreatic beta-cells drives metabolic syndrome in mice.
    PLoS One. 2022;17:e0279560.
    >> Share

  94. SEQUEIRA IR, Yip W, Lu LW, Jiang Y, et al
    Exploring the relationship between pancreatic fat and insulin secretion in overweight or obese women without type 2 diabetes mellitus: A preliminary investigation of the TOFI_Asia cohort.
    PLoS One. 2022;17:e0279085.
    >> Share

    January 2021
  95. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    >> Share

  96. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    >> Share

  97. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    >> Share

  98. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    >> Share

  99. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    >> Share

  100. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    >> Share

  101. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    >> Share

  102. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    >> Share

  103. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    >> Share

  104. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    >> Share

  105. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    >> Share

  106. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    >> Share

  107. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    >> Share

  108. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    >> Share

  109. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    >> Share

  110. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    >> Share

  111. TARTAGLIONE S, Mancini P, Viggiani V, Chirletti P, et al
    PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    PLoS One. 2021;16:e0251656.
    >> Share

  112. TIAN T, Yang Q, Zhang C, Li X, et al
    MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2021;16:e0249375.
    >> Share

  113. ANTWI K, Wiesner P, Merkle EM, Zech CJ, et al
    Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
    PLoS One. 2021;16:e0253078.
    >> Share

  114. KATO T, Ono H, Fujii M, Akahoshi K, et al
    Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
    PLoS One. 2021;16:e0252917.
    >> Share

  115. DHAYAT SA, Tamim ANJ, Jacob M, Ebeling G, et al
    Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    PLoS One. 2021;16:e0252727.
    >> Share

  116. MALHOTRA A, Rachet B, Bonaventure A, Pereira SP, et al
    Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.
    PLoS One. 2021;16:e0251876.
    >> Share

  117. RAJA A, Malik MFA, Haq F
    Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    PLoS One. 2021;16:e0252344.
    >> Share

  118. PEISL S, Mellenthin C, Vignot L, Gonelle-Gispert C, et al
    Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
    PLoS One. 2021;16:e0252397.
    >> Share

  119. UDRISTOIU AL, Cazacu IM, Gruionu LG, Gruionu G, et al
    Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model.
    PLoS One. 2021;16:e0251701.
    >> Share

  120. ULLGREN H, Fransson P, Olofsson A, Segersvard R, et al
    Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    PLoS One. 2021;16:e0254673.
    >> Share

  121. ITO G, Kawakami K, Aoyama T, Yokokawa T, et al
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021;16:e0254726.
    >> Share

  122. STREICHER SA, Lim U, Park SL, Li Y, et al
    Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study.
    PLoS One. 2021;16:e0249615.
    >> Share

  123. IMURA T, Inagaki A, Igarashi Y, Goto M, et al
    Optimization of dye solutions for detecting damaged pancreatic tissues during islet isolation procedures.
    PLoS One. 2021;16:e0255733.
    >> Share

  124. KAFITA D, Nkhoma P, Zulu M, Sinkala M, et al
    Proteogenomic analysis of pancreatic cancer subtypes.
    PLoS One. 2021;16:e0257084.
    >> Share

  125. BARKO PC, Williams DA
    Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency.
    PLoS One. 2021;16:e0257856.
    >> Share

  126. GAO Y, Wang M, Guo X, Hu J, et al
    Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    PLoS One. 2021;16:e0250539.
    >> Share

  127. WESTENFELDER C, Hu Z, Zhang P, Gooch A, et al
    Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
    PLoS One. 2021;16:e0259043.
    >> Share

  128. WAKIYA T, Ishido K, Kimura N, Nagase H, et al
    Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree.
    PLoS One. 2021;16:e0259682.
    >> Share

  129. MAEDA K, Kuriyama N, Nakagawa Y, Ito T, et al
    Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection.
    PLoS One. 2021;16:e0259701.
    >> Share

  130. XU YF, Xu X, Bhandari K, Gin A, et al
    Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    PLoS One. 2021;16:e0259563.
    >> Share

  131. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    >> Share

  132. LI X, Yang Q, Ye H, Li S, et al
    Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence.
    PLoS One. 2021;16:e0260001.
    >> Share

  133. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    >> Share

  134. CHERUBINI A, Rusconi F, Lazzari L
    Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.
    PLoS One. 2021;16:e0260902.
    >> Share

  135. WEEGH N, Zentrich E, Zechner D, Struve B, et al
    Voluntary wheel running behaviour as a tool to assess the severity in a mouse pancreatic cancer model.
    PLoS One. 2021;16:e0261662.
    >> Share

  136. WURTZEL JGT, Lazar S, Sikder S, Cai KQ, et al
    Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice.
    PLoS One. 2021;16:e0261633.
    >> Share

  137. PHILLIP V, Schwab M, Haf D, Algul H, et al
    Correction: Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
    PLoS One. 2021;16:e0261576.
    >> Share

    January 2020
  138. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    >> Share

  139. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    >> Share

  140. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    >> Share

  141. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    >> Share

  142. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    >> Share


  143. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    >> Share

  144. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    >> Share

  145. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    >> Share

  146. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    >> Share

  147. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    >> Share

  148. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    >> Share

  149. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    >> Share

  150. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    >> Share

  151. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    >> Share

  152. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    >> Share

  153. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    >> Share

  154. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    >> Share

  155. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    >> Share

  156. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016